{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Firma Boehringer Ingelheim sai Euroopa Ravimiameti inimravimite komiteelt (CHMP) positiivse hinnangu nintedaniibi kasutamiseks süsteemse skleroosiga seotud interstitsiaalse kopsuhaiguse ravis",
    "url": "https://www.med24.ee/partnerite-uudised/firma-boehringer-ingelheim-sai-euroopa-ravimiameti-inimravimite-komiteelt-chmp-positiivse-hinnangu-nintedaniibi-kasutamiseks-suesteemse-skleroosiga-seotud-interstitsiaalse-kopsuhaiguse-ravis/408936",
    "author_name": "med24",
    "author_url": "https://www.med24.ee",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"408936\" data-lab-site=\"www.med24.ee\"><script async defer src=\"https://www.med24.ee/embed.js?v=335\"></script></div>"
}